We are live on
!
Find out more
NCM
Narwhal Capital Management Portfolio holdings
AUM
$1.45B
1-Year Est. Return
28.39%
This Fund
S&P 500
This Quarter
Est. Return
+10.15%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$752M
AUM Growth
+$61.4M
(+8.9%)
Cap. Flow
-$5.24M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
35.98%
Holding
169
New
16
Increased
54
Reduced
64
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$3.1M |
| 2 |
Philip Morris
PM
|
+$2.11M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$2.11M |
| 4 |
Entegris
ENTG
|
+$1.89M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.72M |
| 2 |
Adobe
ADBE
|
+$2.37M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.94M |
| 4 |
Deere & Co
DE
|
+$1.89M |
| 5 |
Walt Disney
DIS
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.8% |
| 2 | Healthcare | 12.55% |
| 3 | Financials | 9.82% |
| 4 | Consumer Staples | 9.46% |
| 5 | Industrials | 8.95% |
Similar funds
SIA
VIP
SIM
CHAM
HTI
SWP
L7C
WBC
Narwhal Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Narwhal Capital Management held 169 positions worth $752M, up 8.9% from $691M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Narwhal Capital Management's Q4 2022 filing shows 16 new, 54 increased, 64 reduced and 8 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 15,900 shares worth $2.16M. The largest sale was Pfizer, an estimated $2.72M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Narwhal Capital Management's largest Q4 2022 buy was State Street Health Care Select Sector SPDR ETF: 15,900 shares worth $2.16M.
- Narwhal Capital Management added most to RTX Corp in Q4 2022, an estimated $3.1M increase.
- Narwhal Capital Management's biggest Q4 2022 reduction was Pfizer, cutting an estimated $2.72M.
- Narwhal Capital Management fully exited ProShares UltraPro Short S&P 500 in Q4 2022, selling an estimated $390K.
- Narwhal Capital Management's ten largest holdings make up 36% of its $752M portfolio in Q4 2022.
- Narwhal Capital Management opened 16 new positions and closed 8 in Q4 2022.
- Narwhal Capital Management's portfolio value rose 8.9% quarter-over-quarter to $752M.
Based on Narwhal Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.